Itemoids

You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

2026February › 11

Moderna

5 months ago

CEO Stephane Bancel said the letter refusing review did not cite 'any safety or efficacy concerns'.
These are the stocks posting the largest moves in midday trading.
These are the stocks posting the largest moves in early trading.
Moderna said the move is inconsistent with previous feedback from the FDA on the experimental influenza shot, called mRNA-1010.

page 1 of 1